conduct
retrospect
close
cohort
studi
among
pupil
parent
sibl
well
teacher
nonteach
staff
highschool
locat
ois
particip
complet
questionnair
cover
histori
fever
andor
respiratori
symptom
sinc
januari
blood
test
presenc
antibodi
infect
attack
rate
iar
defin
proport
particip
confirm
infect
base
antibodi
detect
blood
sampl
two
blood
donor
centr
collect
march
ois
depart
also
test
presenc
antibodi
find
particip
median
age
year
particip
antibodi
overal
iar
confid
interv
ci
infect
fatal
rate
onesid
ci
nine
ten
particip
hospitalis
sinc
midjanuari
infect
group
give
hospitalis
rate
ci
anosmia
ageusia
high
posit
predict
valu
infect
respect
smoker
lower
iar
compar
nonsmok
versu
p
proport
infect
individu
symptom
studi
period
ci
proport
donor
antibodi
two
nearbi
blood
bank
ois
depart
ci
rel
low
iar
observ
area
activ
circul
week
confin
measur
indic
establish
herd
immun
take
time
lift
measur
franc
long
complex
evid
studi
first
case
franc
report
januari
substanti
transmiss
occur
sinc
ois
depart
north
pari
one
heaviest
affect
area
earli
stage
epidem
franc
april
case
diagnos
franc
includ
death
epidemiolog
clinic
characterist
patient
wide
report
larg
centr
case
requir
medic
care
remain
unclear
stage
extent
infect
may
asymptomat
present
subclin
nonspecif
symptom
extens
contact
trace
identifi
asymptomat
infect
use
rtpcr
test
serolog
detect
antibodi
need
determin
real
infect
attack
rate
proport
infect
asymptomat
subclin
use
combin
serolog
assay
high
sensit
specif
antibodi
conduct
retrospect
close
cohort
studi
high
school
link
cluster
ois
depart
show
overal
infect
attack
rate
iar
high
school
group
parent
sibl
pupil
proport
infect
individu
symptom
studi
period
rel
low
iar
area
activ
circul
confin
measur
introduc
indic
establish
herd
immun
take
time
lift
measur
franc
long
complex
sever
acut
respiratori
syndrom
novel
coronaviru
first
report
world
health
organ
cluster
viral
pneumonia
case
unknown
etiolog
wuhan
china
decemb
known
caus
coronaviru
diseas
primarili
affect
upper
lower
respiratori
tract
januari
declar
outbreak
constitut
public
health
emerg
intern
concern
sinc
outbreak
continu
spread
around
world
describ
pandem
march
first
three
case
identifi
franc
report
januari
travel
return
wuhan
china
februari
patient
ois
depart
north
pari
admit
hospit
pari
critic
condit
diagnos
infect
die
februari
first
report
case
franc
without
direct
indirect
epidemiolog
link
china
ensu
epidemiolog
investig
led
identif
cluster
involv
high
school
ois
depart
emerg
infecti
diseas
includ
initi
surveil
focus
primarili
sever
infect
lead
overestim
case
fatal
rate
cfr
likewis
absenc
knowledg
subclin
asymptomat
form
infect
possibl
estim
infect
fatal
rate
ifr
except
mathemat
model
howev
populationbas
serolog
investig
use
serolog
assay
determin
infect
attack
rate
iar
popul
epidem
area
abl
determin
proport
subclin
asymptomat
infect
inform
key
better
understand
circul
precis
estim
fatal
rate
calibr
mathemat
model
use
forecast
dynam
ongo
epidem
date
access
valid
serolog
assay
limit
howev
seri
serolog
assay
recent
develop
institut
pasteur
pari
franc
shown
high
sensit
specif
detect
antibodi
describ
retrospect
close
cohort
studi
aim
estim
iar
determin
area
affect
use
serolog
assay
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
follow
confirm
patient
ois
depart
case
investig
contact
trace
identifi
two
case
high
school
symptom
consist
februari
suggest
circul
viru
ois
depart
sinc
end
januari
followup
initi
case
investig
contact
trace
retrospect
close
cohort
studi
conduct
high
school
march
april
pupil
well
teacher
nonteach
staff
administr
cleaner
cater
high
school
invit
particip
investig
sinc
pupil
minor
least
one
parent
invit
particip
studi
provid
inform
consent
child
children
age
year
household
enrol
studi
follow
inform
consent
particip
complet
questionnair
cover
sociodemograph
inform
underli
medic
condit
histori
symptom
sinc
januari
histori
diagnosi
prior
investig
ml
blood
sampl
taken
particip
irrespect
whether
report
fever
respiratori
symptom
sinc
januari
march
serum
sampl
collect
two
blood
donat
centr
locat
km
place
seroepidemiolog
investig
serum
sampl
test
antibodi
respons
use
sever
assay
develop
institut
pasteur
elisa
n
assay
detect
antibodi
bind
n
protein
sflow
assay
flowcytometri
base
assay
detect
anti
igg
lip
assay
immunoprecipitationbas
assay
detect
antin
igg
particip
consid
seroposit
test
posit
sinc
test
specif
higher
cutoff
chosen
posit
particip
posit
serolog
time
blood
sampl
consid
confirm
infect
infect
categoris
symptomat
symptom
report
particip
sinc
januari
altern
asymptomat
symptom
consid
occur
least
day
prior
date
blood
sampl
collect
allow
time
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
seroconvers
symptom
categor
major
fever
dri
cough
dyspnoea
anosmia
ageusia
minor
sore
throat
rhiniti
muscl
pain
diarrhoea
headach
asthenia
infect
attack
rate
iar
defin
proport
particip
confirm
infect
base
antibodi
detect
compar
age
sex
occup
smoke
comorbid
condit
recent
symptom
use
chisquar
test
logist
regress
use
adjust
age
occup
analys
associ
smoke
infect
studi
regist
clinicaltrialsgov
receiv
ethic
approv
de
protect
de
personn
ile
de
franc
iii
inform
consent
obtain
particip
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
march
april
high
school
pupil
teacher
nonteach
staff
invit
email
particip
investig
email
address
avail
respond
accept
particip
studi
addit
parent
sibl
high
school
pupil
also
invit
particip
studi
form
studi
popul
particip
see
figur
tabl
indic
characterist
particip
pupil
parent
constitut
major
studi
popul
respect
median
age
year
iqr
male
overal
particip
report
respiratori
symptom
januari
one
week
blood
sampl
major
symptom
experienc
studi
particip
minor
symptom
notic
symptom
period
cover
studi
common
symptom
rhiniti
follow
cough
tabl
show
proport
antibodi
differ
iar
male
femal
iar
highest
year
age
group
iar
higher
high
school
group
pupil
teacher
school
staff
respect
parent
sibl
respect
p
smoke
found
associ
lower
risk
infect
versu
smoker
nonsmok
respect
p
ci
associ
remain
signific
adjust
age
ci
occup
ci
increas
iar
among
comorbid
otherwis
known
associ
sever
form
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
particip
experienc
major
symptom
like
infect
compar
minor
symptom
respect
p
symptom
consid
two
high
posit
predict
valu
infect
anosmia
ageusia
anosmia
ageusia
neg
serolog
find
time
report
symptom
blood
sampl
longer
one
month
neg
serolog
find
unlik
reflect
delay
seroconvers
dramat
week
correspond
begin
school
holiday
local
confin
measur
introduc
ois
depart
seen
figur
symptom
among
infect
suggest
respiratori
virus
circul
commun
studi
period
serum
sampl
collect
two
blood
donat
centr
march
ci
antibodi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
knowledg
first
studi
estim
antibodi
detect
iar
infect
commun
affect
fist
descript
outbreak
school
cluster
estim
iar
approxim
week
like
introduct
circul
commun
epidem
presum
start
third
week
januari
continu
school
closur
holiday
februari
declin
follow
introduct
confin
measur
march
confirm
case
week
iar
highest
among
high
school
staff
teacher
pupil
much
lower
among
parent
sibl
pupil
secondari
iar
household
similar
among
parent
sibl
close
observ
studi
shenzen
china
context
ongo
debat
around
contribut
children
school
viral
transmiss
find
interest
impact
school
closur
epidem
dynam
particularli
strike
limit
find
restrict
high
school
set
high
school
pupil
teacher
compar
iar
similar
observ
iceland
compar
viral
detect
proport
year
old
adult
target
test
group
infect
studi
popul
overal
hospitalis
rate
death
observ
rel
low
figur
need
consid
young
age
larg
part
studi
popul
year
age
median
age
year
two
older
year
current
understand
sever
clinic
present
hospitalis
rate
cfr
lower
among
younger
age
group
iar
higher
among
major
symptom
compar
minor
symptom
document
anosmia
ageusia
high
predict
valu
infect
symptom
studi
period
true
proport
asymptomat
infect
like
higher
sinc
symptom
among
infect
may
also
attribut
respiratori
virus
circul
commun
time
period
smoker
lower
iar
compar
nonsmok
associ
remain
adjust
age
occup
earlier
studi
china
us
document
low
proport
smoker
among
patient
hospitalis
patient
wuhan
patient
us
protect
associ
smoke
studi
substanti
decreas
risk
infect
deserv
full
attent
one
possibl
explan
would
downregul
receptor
nicotin
find
need
replic
solid
understand
physiopatholog
process
underli
care
consider
light
increas
risk
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
sever
form
among
smoker
infect
longterm
harm
consequ
smoke
main
limit
studi
rel
low
particip
rate
among
invit
difficult
specul
whether
led
overestim
felt
well
studi
period
come
underestim
pcrconfirm
diagnosi
studi
period
come
iar
nevertheless
overal
find
consist
literatur
date
term
overal
agestandardis
cfr
hospitalis
rate
predict
valu
symptom
ageusia
anosmia
possibl
effect
school
closur
respiratori
virus
epidem
dynam
clinic
find
investig
also
limit
fact
symptom
retrospect
selfreport
absenc
clinic
evalu
respiratori
virus
presum
circul
time
studi
popul
choic
serolog
test
challeng
absenc
valid
assay
select
three
serolog
method
high
specif
posit
signal
three
test
would
consid
true
posit
combin
high
sensit
one
three
method
sflow
assay
suggest
abl
captur
individu
antibodi
concern
relat
antibodi
kinet
infect
patient
seroconvert
within
two
week
onset
symptom
clear
whether
time
seroconvers
may
longer
patient
asymptomat
subclin
infect
case
estim
iar
might
underestim
true
one
still
lockdown
place
four
week
blood
sampl
believ
time
seroconvers
suffici
major
infect
individu
one
import
knowledg
gap
remain
extent
antibodi
detect
studi
would
immunoprotect
absenc
knowledg
suggest
barrier
measur
social
distanc
continu
appli
way
peopl
without
antibodi
also
found
blood
donor
resid
surround
area
evid
antibodi
proport
may
seem
low
despit
circul
viru
region
fraction
like
lower
true
seropreval
among
adult
region
number
reason
blood
donor
tend
health
consciou
allow
give
blood
ill
month
tend
refrain
donat
blood
famili
member
recent
ill
nonetheless
track
seroposit
blood
donor
time
give
indic
trend
antibodi
dynam
gener
popul
reason
use
effect
previou
epidem
includ
pandem
influenza
zika
viru
repeat
serolog
test
antibodi
blood
donor
popul
need
continu
affect
unaffect
area
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
overal
find
studi
import
implic
public
health
measur
outbreak
investig
specif
overal
iar
commun
live
within
epicentr
epidem
franc
low
preval
antibodi
among
blood
donor
vicin
suggest
herd
immun
establish
quickli
area
franc
viru
circul
remain
immunolog
naiv
viru
sinc
march
french
govern
implement
public
health
measur
restrict
movement
individu
outsid
home
find
studi
suggest
lift
confin
measur
may
long
complex
reason
effect
therapeut
treatment
vaccin
specif
urgent
need
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
author
critic
review
approv
final
version
manuscript
declar
compet
interest
sandrin
ropar
nicol
correcatelin
laurenc
arowa
mamou
traor
particip
organis
implement
field
investig
final
would
like
thank
fabric
carrat
dominiqu
costagliola
critic
read
manuscript
use
comment
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
supplementari
materi
tabl
seroposit
accord
symptom
sever
serolog
assay
perform
serum
sampl
particip
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
major
symptom
includ
fever
cough
dyspnea
anosmia
ageusia
minor
symptom
includ
sore
throat
rhiniti
myalgia
diarrhea
headach
asthenia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
